Browsing by Author "Bidard, François-Clement"
Now showing items 1-3 of 3
-
Elacestrant (oral selective estrogen receptor degrader) Versus Standard Endocrine Therapy for Estrogen Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer: Results From the Randomized Phase III EMERALD Trial
Bidard, François-Clement; Kaklamani, Virginia; Neven, Patrick; Streich, Guillermo; Montero, Alberto J.; Forget, Frédéric; Cortés Castan, Javier (American Society of Clinical Oncology, 2022-10-01) -
ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group
Pascual, Javier; Attard, Gerhardt; Bidard, François-Clement; De Mattos-Arruda, Leticia; Diehn, Maximilian; Seoane Suarez, Joan; Curigliano, Giuseppe (Elsevier, 2022-08) -
Neratinib in patients with HER2 -mutant, metastatic cervical cancer: Findings from the phase 2 SUMMIT basket trial
Oaknin Benzaquen, Ana Mazaltob; Friedman, Claire F.; Roman, Lynda D.; D'Souza, Anishka; Braña Garcia, Irene; Bidard, François-Clement (Elsevier, 2020-10)